Senior Management

Søren Bregenholt
CEO
    • Independent in relation to the Company and its management: No
    • Independent in relation to major shareholders: Yes
    • Holdings in Alligator: 1,103,019 shares, 500,000 warrants in program TO 2022/2025 I, 1,200,000 warrants in program TO 2023/2026 I, 900,000 warrants in program TO 2024/2027 I and 194,666 warrants in program TO 9.
    • Other current positions: Chairman of Medicon Valley Alliance, Chairman of A Bioscience Incentive AB and Atlas Therapeutics AB, and Board member of Oblique Therapeutics AB (publ).
    Peter Ellmark
    CSO
      • Independent in relation to the Company and its management: No
      • Independent in relation to major shareholders: Yes
      • Holdings in Alligator: 98,720 shares, 250,000 warrants in program TO 2022/2025 I, and 600,000 warrants in program TO 2023/2026 I.
      • Other current positions: None
      Johan Giléus
      CFO
        • Independent in relation to the Company and its management: No
        • Independent in relation to major shareholders: Yes
        Laura von Schantz
        CTO
          • Independent in relation to the Company and its management: No
          • Independent in relation to major shareholders: Yes
          • Holdings in Alligator: 10,504 shares, 77,000 warrants in program TO 2022/2025 I, and 100,000 warrants in program TO 2024/2027 I.
          • Other current positions: None
          Dr. Sumeet Ambarkhane
          CMO
            • Independent in relation to the Company and its management: No
            • Independent in relation to major shareholders: Yes
            • Holdings in Alligator: 54,205 shares and 250,000 warrants in program TO 2022/2025 I.
            • Other current positions: Inga
            Updated 2024-08-12